TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34008876

Group type: EXPERIMENTAL
Intervention: MR Steiger approach
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MR Steiger method applied to COPDGene study
Number of subjects: 0
Study: 33275382

Group type: EXPERIMENTAL
Intervention: Multimodal exercise intervention (Healthy Body Healthy Mind) plus usual care
Number of subjects: 13
Study: 35986466

Group type: EXPERIMENTAL
Intervention: Spirulina 500 mg twice daily along with topical triamcinolone acetonide 0.1% thrice daily for one week
Number of subjects: 60

Group type: COMPARATOR
Intervention: Topical triamcinolone acetonide 0.1% alone thrice daily for 8 weeks
Number of subjects: 60
Study: 35777696

Group type: EXPERIMENTAL
Intervention: HIV-Pain and Sadness Support (HIVPASS) intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Health Education (HE) condition
Number of subjects: 0
Study: 35162263

Group type: COMPARATOR
Intervention: Control (gentle touch + human voice)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Control + breast milk odor
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Control + breast milk odor + breast milk taste
Number of subjects: 114
Study: 33734575

Group type: EXPERIMENTAL
Intervention: LONGTY DCB
Number of subjects: 211

Group type: COMPARATOR
Intervention: SeQuent Please DCB
Number of subjects: 211
Study: 32639800

Group type: EXPERIMENTAL
Intervention: Quantum information scrambling on a 10-qubit trapped-ion quantum simulator
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Decoherence analysis
Number of subjects: 10
Study: 34982738

Group type: EXPERIMENTAL
Intervention: IV vitamin C (1,000 mg bolus over 30 minutes followed by continuous infusion of 250 mg/hr for 96 hours)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: IV vitamin C
Number of subjects: 124

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 124
Study: 33949215

Group type: EXPERIMENTAL
Intervention: 3-month intervention fostering self-efficacy and social support through weekly, family-centered sessions
Number of subjects: 136
Study: 33125362

Group type: EXPERIMENTAL
Intervention: WBRT+RF-IMRT
Number of subjects: 200

Group type: COMPARATOR
Intervention: CF-IMRT
Number of subjects: 200
Study: 34726703

Group type: EXPERIMENTAL
Intervention: GOS (15 g) with FeFum (14 mg)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control (FeFum 14 mg without GOS)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: GOS and SF interaction
Number of subjects: 11
Study: 34408611

Group type: EXPERIMENTAL
Intervention: Scapulothoracic MWM + corrective exercises + tape
Number of subjects: 40

Group type: COMPARATOR
Intervention: Corrective exercises + tape
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40

Group type: COMPARATOR
Intervention: Comparison group
Number of subjects: 40
Study: 33301338

Group type: EXPERIMENTAL
Intervention: Mortality salience
Number of subjects: 128

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 128
Study: 33135385

Group type: EXPERIMENTAL
Intervention: Patient empowerment program (PEP) combined with cognitive training (CT) for 10 weeks
Number of subjects: 139

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 139
Study: 35720910

Group type: EXPERIMENTAL
Intervention: Intelligent wearable device combined with IARA and Orem self-care model
Number of subjects: 60

Group type: COMPARATOR
Intervention: IARA intervention model combined with Orem self-care model
Number of subjects: 60
Study: 34314615

Group type: EXPERIMENTAL
Intervention: 80% oxygen (FIO2)
Number of subjects: 178

Group type: COMPARATOR
Intervention: 30% oxygen (FIO2)
Number of subjects: 178
Study: 35583400

Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS) combined with physiotherapy
Number of subjects: 52

Group type: COMPARATOR
Intervention: Physiotherapy alone
Number of subjects: 52
Study: 33749992

Group type: EXPERIMENTAL
Intervention: Platelet gel (PG)
Number of subjects: 0
Study: 32139353

Group type: EXPERIMENTAL
Intervention: Endurance Exercise (EE)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Resistance Exercise (RE)
Number of subjects: 24
Study: 34498896

Group type: EXPERIMENTAL
Intervention: Recovering Together (RT)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Health education attention placebo control
Number of subjects: 58
Study: 34630103

Group type: EXPERIMENTAL
Intervention: Metformin 850 mg twice daily
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 36142984

Group type: EXPERIMENTAL
Intervention: Dual-plane ultrasonic scan-assisted spinal anesthesia (Group B)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Single-plane ultrasonic scan-assisted spinal anesthesia (Group A)
Number of subjects: 120
Study: 33395140

Group type: EXPERIMENTAL
Intervention: Transversus abdominis plane block
Number of subjects: 347

Group type: COMPARATOR
Intervention: No transversus abdominis plane block
Number of subjects: 347
Study: 36374528

Group type: EXPERIMENTAL
Intervention: Crushed tebipenem via NGT
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Crushed tebipenem via NGT with enteral feeds
Number of subjects: 12

Group type: COMPARATOR
Intervention: Whole tablet oral administration (reference formulation)
Number of subjects: 12
Study: 33256796

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment for 4 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham acupuncture treatment for 4 weeks
Number of subjects: 60
Study: 34090773

Group type: EXPERIMENTAL
Intervention: Dietary fiber (oat bran) supplement (30 g/d, containing DF 8.9 g)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Dietary fiber (oat bran) supplement
Number of subjects: 50
Study: 35394413

Group type: EXPERIMENTAL
Intervention: Traditional training program (4 sets of 8 repetitions, 10 repetition maximum load, 5 min rest between sets and exercises)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Rest-redistribution training program (16 sets of 2 repetitions, 1 min rest between sets, 5 min rest between exercises)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 39
Study: 33784885

Group type: EXPERIMENTAL
Intervention: Randomization methods for identifying rules of interaction
Number of subjects: 0
Study: 34924237

Group type: EXPERIMENTAL
Intervention: Prasugrel
Number of subjects: 1131

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 1131

Group type: EXPERIMENTAL
Intervention: SNT > 4 hours in high-risk group
Number of subjects: 1131
Study: 33588087

Group type: EXPERIMENTAL
Intervention: 0.07 mg LOR
Number of subjects: 695

Group type: EXPERIMENTAL
Intervention: 0.23 mg LOR
Number of subjects: 695

Group type: COMPARATOR
Intervention: PBO
Number of subjects: 695
Study: 33099300

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 35099281

Group type: EXPERIMENTAL
Intervention: 80% basal insulin reduction applied 40 minutes before exercise onset (T-40)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 80% basal insulin reduction applied 90 minutes before exercise onset (T-90)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Comparison between T-40 and T-90
Number of subjects: 20
Study: 33045417

Group type: EXPERIMENTAL
Intervention: 6 million MPCs with HA
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 18 million MPCs with HA
Number of subjects: 100

Group type: COMPARATOR
Intervention: HA vehicle control
Number of subjects: 100

Group type: COMPARATOR
Intervention: Saline control (placebo)
Number of subjects: 100
Study: 33423376

Group type: EXPERIMENTAL
Intervention: Manual Therapy (MT)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 17
Study: 32992998

Group type: EXPERIMENTAL
Intervention: Conventional resistance exercise followed by self‐myofascial release (CEBR)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Eccentric‐only exercise (ECC)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Plyometric jumps (PLY)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Conventional resistance exercise
Number of subjects: 26

Group type: COMPARATOR
Intervention: Non-trained leg
Number of subjects: 26
Study: 35803494

Group type: EXPERIMENTAL
Intervention: 2-in-1 design with graphical approach
Number of subjects: 0
Study: 34283040

Group type: EXPERIMENTAL
Intervention: Immersive experience using a mobile phone-based head-mounted display
Number of subjects: 90

Group type: COMPARATOR
Intervention: Intravenous midazolam sedation
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 90
Study: 34788593

Group type: EXPERIMENTAL
Intervention: WFG-LASIK
Number of subjects: 44

Group type: COMPARATOR
Intervention: SMILE
Number of subjects: 44
Study: 34106628

Group type: EXPERIMENTAL
Intervention: Acupoint massage
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Relaxation therapy
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Acupoint massage combined with relaxation therapy
Number of subjects: 180

Group type: COMPARATOR
Intervention: Conventional treatment (Control group)
Number of subjects: 180
Study: 34014714

Group type: EXPERIMENTAL
Intervention: Vocational Peer Support (VPS)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Peer support services-as-usual
Number of subjects: 166
Study: 36240693

Group type: EXPERIMENTAL
Intervention: Thin-ideal social media images
Number of subjects: 260

Group type: COMPARATOR
Intervention: Average size social media images
Number of subjects: 260
Study: 33564835

Group type: EXPERIMENTAL
Intervention: Hyrax (H)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Hybrid-Hyrax (HH)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Keles keyless expander (K)
Number of subjects: 66
Study: 35804049

Group type: EXPERIMENTAL
Intervention: 0.01% atropine
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 32870340

Group type: EXPERIMENTAL
Intervention: Vaginal hysterectomy with uterosacral ligament suspension
Number of subjects: 94

Group type: COMPARATOR
Intervention: Vaginal mesh hysteropexy
Number of subjects: 94
Study: 35506334

Group type: EXPERIMENTAL
Intervention: Lemborexant
Number of subjects: 0

Group type: COMPARATOR
Intervention: Suvorexant
Number of subjects: 0

Group type: COMPARATOR
Intervention: Zolpidem immediate release (IR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Untreated insomnia
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lemborexant vs Suvorexant
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lemborexant vs Zolpidem-IR
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lemborexant vs Untreated insomnia
Number of subjects: 0
Study: 33274588

Group type: EXPERIMENTAL
Intervention: Single use negative pressure dressing (SUNPD)
Number of subjects: 840

Group type: COMPARATOR
Intervention: Surgeon's preference of dressing
Number of subjects: 840
Study: 35916755

Group type: EXPERIMENTAL
Intervention: MBCT + TAU (n = 23)
Number of subjects: 49

Group type: COMPARATOR
Intervention: TAU (n = 26)
Number of subjects: 49
Study: 32310620

Group type: EXPERIMENTAL
Intervention: linaclotide 145 µg
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: linaclotide 290 µg
Number of subjects: 254

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 254
Study: 36906404

Group type: EXPERIMENTAL
Intervention: IIV4-HD (high-dose quadrivalent inactivated influenza vaccine) administered intramuscularly (IM)
Number of subjects: 2100

Group type: COMPARATOR
Intervention: IIV4-SD (standard-dose influenza vaccine) administered subcutaneously (SC)
Number of subjects: 2100
Study: 33260212

Group type: EXPERIMENTAL
Intervention: Peer input intervention
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 28
Study: 34098686

Group type: EXPERIMENTAL
Intervention: Visualized saphenous nerve block combined with periarticular infiltration analgesia (Group VSNB+PIA)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Only periarticular infiltration analgesia (Group PIA)
Number of subjects: 100
Study: 33201245

Group type: EXPERIMENTAL
Intervention: Virtual Reality-based rehabilitation (VR) in addition to standard care (SC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 0
Study: 32981097

Group type: EXPERIMENTAL
Intervention: Crisaborole ointment, 2%, applied twice daily for 28 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 0
Study: 36048453

Group type: EXPERIMENTAL
Intervention: modified FOLFIRINOX (oxaliplatin, 85 mg/m2; irinotecan, 150-180 mg/m2; leucovorin, 400 mg/m2; fluorouracil, 2400 mg/m2, every 2 weeks)
Number of subjects: 493

Group type: COMPARATOR
Intervention: gemcitabine (1000 mg/m2, days 1, 8, and 15, every 4 weeks)
Number of subjects: 493

Group type: EXPERIMENTAL
Intervention: modified FOLFIRINOX
Number of subjects: 493

Group type: COMPARATOR
Intervention: gemcitabine
Number of subjects: 493
Study: 33628758

Group type: EXPERIMENTAL
Intervention: Energy-restricted anti-inflammatory diet
Number of subjects: 81
Study: 32815838

Group type: EXPERIMENTAL
Intervention: Total Elbow Arthroplasty (TEA)
Number of subjects: 664

Group type: COMPARATOR
Intervention: Open Reduction Internal Fixation (ORIF)
Number of subjects: 664
Study: 35121633

Group type: EXPERIMENTAL
Intervention: Immediate smoking cessation support with pharmacotherapy
Number of subjects: 115

Group type: COMPARATOR
Intervention: Usual care (Very Brief Advice to quit and signposting to smoking cessation services)
Number of subjects: 115
Study: 34373201

Group type: EXPERIMENTAL
Intervention: Ocufilcon D (hydrogel) contact lenses
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Somofilcon A (silicone hydrogel) contact lenses
Number of subjects: 20

Group type: COMPARATOR
Intervention: Both contact lenses
Number of subjects: 20
Study: 33397410

Group type: EXPERIMENTAL
Intervention: Male partners' intention to provide breastfeeding appreciation
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Male partners' intention to provide breastfeeding presence
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Male partners' intention to provide breastfeeding responsiveness
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Multiparous mothers' perceptions of partners' breastfeeding savvy
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Multiparous mothers' perceptions of partners' breastfeeding help
Number of subjects: 128
Study: 35570289

Group type: EXPERIMENTAL
Intervention: Family Connections - SBD (FC-SBD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as Usual Optimized (TAU-O)
Number of subjects: 0
Study: 33752741

Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir (LPV/r) 800/200 mg twice daily for 14 days
Number of subjects: 1220

Group type: COMPARATOR
Intervention: No intervention (control arm)
Number of subjects: 1220

Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir (LPV/r)
Number of subjects: 1220
Study: 34644618

Group type: EXPERIMENTAL
Intervention: Modified electroconvulsive therapy (MECT)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (drugs alone)
Number of subjects: 64
Study: 32567975

Group type: EXPERIMENTAL
Intervention: Cognitively-engaging intervention
Number of subjects: 891

Group type: EXPERIMENTAL
Intervention: Aerobic intervention
Number of subjects: 891

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 891
Study: 33788249

Group type: EXPERIMENTAL
Intervention: Flow‐I with automated gas control
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Aisys with automated gas control
Number of subjects: 160

Group type: COMPARATOR
Intervention: Conventional low flow anaesthesia (Flow‐I)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Conventional low flow anaesthesia (Aisys)
Number of subjects: 160
Study: 32302693

Group type: EXPERIMENTAL
Intervention: Febuxostat, 40 mg daily during acute gout attack
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (febuxostat, 40 mg daily after attacks)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Febuxostat and Control
Number of subjects: 52
Study: 35395497

Group type: EXPERIMENTAL
Intervention: Physical exercise break (PE group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Prolonged sitting (PS group)
Number of subjects: 60
Study: 34127492

Group type: EXPERIMENTAL
Intervention: Natural Language Processing (NLP) on free-text clinical notes and reports
Number of subjects: 800

Group type: COMPARATOR
Intervention: Manual medical record review by trained ARIC abstractors (reference standard)
Number of subjects: 800
Study: 32996583

Group type: EXPERIMENTAL
Intervention: Computer-assisted cognitive rehabilitation with a neuropsychologist (Group A)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Home cognitive self-exercises (Group B)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Phone follow-up (Group C)
Number of subjects: 167
Study: 36254728

Group type: EXPERIMENTAL
Intervention: Drug-Eluting Stent (DES)
Number of subjects: 775

Group type: COMPARATOR
Intervention: Bare Metal Stent (BMS)
Number of subjects: 775
Study: 34169339

Group type: EXPERIMENTAL
Intervention: ECOG PS > 1
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: BMI > 25 kg/m2
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Intraoperative norepinephrine > 0.11 µg/kg/min
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Intraoperative fresh frozen plasma (FFP) > 17 units
Number of subjects: 106
Study: 33721982

Group type: EXPERIMENTAL
Intervention: High-volume resistance exercise session
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Low-volume resistance exercise session
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control session (no exercise)
Number of subjects: 20
Study: 33827126

Group type: EXPERIMENTAL
Intervention: Remifentanil infusion rate of 0.1 μg/kg/min
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Remifentanil infusion rate of 0.2 μg/kg/min
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Remifentanil infusion rate of 0.4 μg/kg/min
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Local anesthesia with 2% lidocaine containing 12.5 μg/mL epinephrine
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: All groups (0.1, 0.2, 0.4 μg/kg/min)
Number of subjects: 63
Study: 35596187

Group type: EXPERIMENTAL
Intervention: Severely malnourished children (cases)
Number of subjects: 201
Study: 34313843

Group type: EXPERIMENTAL
Intervention: Oral acetaminophen 1 g
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 32265500

Group type: EXPERIMENTAL
Intervention: Dasatinib (100 mg)
Number of subjects: 260

Group type: COMPARATOR
Intervention: Imatinib (≥400 mg)
Number of subjects: 260
Study: 35101100

Group type: EXPERIMENTAL
Intervention: SBIRT (Screening, Brief Intervention, and Referral to Treatment)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Referral as usual (usual care)
Number of subjects: 600
Study: 33626921

Group type: EXPERIMENTAL
Intervention: Weight management program adapted for children with autism; duration: 8 weeks; participation with a parent or adult caregiver.
Number of subjects: 15

Group type: COMPARATOR
Intervention: Weight management program for children without autism; duration: 8 weeks; participation with a parent or adult caregiver.
Number of subjects: 15
Study: 32717956

Group type: EXPERIMENTAL
Intervention: Progressive trunk resistance and stretching exercise program (60-90 min sessions, 3 days per week for 12 weeks)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (not specified what the control intervention was)
Number of subjects: 17
Study: 33692621

Group type: EXPERIMENTAL
Intervention: BreatheMate device with electronic reminders for budesonide/formoterol 160/4.5 μg twice daily
Number of subjects: 138

Group type: COMPARATOR
Intervention: Control group receiving the same medication without electronic reminders
Number of subjects: 138
Study: 34855657

Group type: EXPERIMENTAL
Intervention: Diterpene ginkgolides meglumine injection (DGMI) 25 mg/d for 14 days
Number of subjects: 80
Study: 32291565

Group type: EXPERIMENTAL
Intervention: Dating Matters® Comprehensive Teen Dating Violence Prevention Model
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 36262727

Group type: EXPERIMENTAL
Intervention: 400 μg nitroglycerine (Group N4)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: 800 μg nitroglycerine (Group N8)
Number of subjects: 70
Study: 32522503

Group type: EXPERIMENTAL
Intervention: Bitter-flavoured, 7.5mm film-coated tablets
Number of subjects: 153
Study: 36093873

Group type: EXPERIMENTAL
Intervention: Pre-COVID-19 recruitment
Number of subjects: 485

Group type: EXPERIMENTAL
Intervention: Post-COVID-19 recruitment
Number of subjects: 485

Group type: COMPARATOR
Intervention: Pre-COVID-19 eligibility screening
Number of subjects: 485

Group type: COMPARATOR
Intervention: Demographic comparison
Number of subjects: 485
Study: 33168558

Group type: EXPERIMENTAL
Intervention: In-depth education on risk-reducing behaviours
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 120
Study: 35188874

Group type: EXPERIMENTAL
Intervention: Oral vitamin D supplementation for 8 weeks along with conventional dry eye treatment (artificial tears)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional dry eye treatment (artificial tears) without vitamin D supplementation
Number of subjects: 100
Study: 33236287

Group type: EXPERIMENTAL
Intervention: INTP5 (pegfilgrastim biosimilar)
Number of subjects: 200

Group type: COMPARATOR
Intervention: pegfilgrastim-ref
Number of subjects: 200
Study: 35546255

Group type: EXPERIMENTAL
Intervention: Intradermal hepatitis B vaccine with topical imiquimod pre‐treatment (ID-Imq)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Intramuscular hepatitis B vaccine with aqueous cream pre‐treatment (IM-Aq)
Number of subjects: 104
Study: 32246138

Group type: EXPERIMENTAL
Intervention: Continuous infusion of cefotaxime (250 mg/kg/day) with oral acetaminophen (first dose 30 mg/kg, then 20 mg/kg every 6 hours)
Number of subjects: 375

Group type: COMPARATOR
Intervention: Cefotaxime conventionally as boluses (62.5 mg/kg, 4 times per day) with placebo orally
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: Continuous infusion of cefotaxime with oral acetaminophen
Number of subjects: 375

Group type: COMPARATOR
Intervention: Cefotaxime conventionally as boluses with placebo orally
Number of subjects: 375
Study: 35077452

Group type: EXPERIMENTAL
Intervention: Package of vector control interventions including larvivorous guppy fish, mosquito trapping with gravid-ovitraps, solid waste management, breeding-container coverage through community education and engagement.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control Arm
Number of subjects: 0
Study: 33105394

Group type: EXPERIMENTAL
Intervention: DriSti intervention (2 sessions with videos and interactive exercises on a computer tablet and one interactive face-to-face group session)
Number of subjects: 1492

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 1492